Anhui Fengyuan Pharmaceutical Co Ltd Cash Flow Quality Index
Anhui Fengyuan Pharmaceutical Co Ltd cash flow quality index. Anhui Fengyuan Pharmaceutical Co Ltd (000153) has a Cash Flow Quality Index of 2.88x as of September 2025. Operating cash flow of CN¥69.15 Million exceeds net income of CN¥24.01 Million, indicating high earnings quality where cash backs reported profits. Explore Anhui Fengyuan Pharmaceutical Co Ltd (000153) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Anhui Fengyuan Pharmaceutical Co Ltd (1999–2025)
Cash flow quality index of Anhui Fengyuan Pharmaceutical Co Ltd from 1999 to 2025. Historical Cash Flow Quality Index for Anhui Fengyuan Pharmaceutical Co Ltd across 27 annual periods. Values consistently above 1.0x indicate high-quality earnings. See 000153 equity financing ratio to measure how much of total assets are equity-financed.
Anhui Fengyuan Pharmaceutical Co Ltd Cash Flow Quality Index by Year (1999–2025)
Anhui Fengyuan Pharmaceutical Co Ltd cash flow quality index by year from 1999 to 2025. Year-by-year earnings quality comparison for Anhui Fengyuan Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see 000153 cash flow conversion.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.20x | CN¥119.30 Million | CN¥99.42 Million | ▲ +49.9% |
| 2024 | 0.80x | CN¥126.24 Million | CN¥157.65 Million | ▼ -50.6% |
| 2023 | 1.62x | CN¥254.75 Million | CN¥157.30 Million | ▼ -44.4% |
| 2022 | 2.91x | CN¥439.99 Million | CN¥150.94 Million | ▲ +34.1% |
| 2021 | 2.17x | CN¥237.88 Million | CN¥109.47 Million | ▼ -24.2% |
| 2020 | 2.87x | CN¥292.75 Million | CN¥102.10 Million | ▲ +249.1% |
| 2019 | 0.82x | CN¥66.21 Million | CN¥80.61 Million | ▼ -78.7% |
| 2018 | 3.85x | CN¥233.59 Million | CN¥60.71 Million | ▲ +379.9% |
| 2017 | 0.80x | CN¥52.40 Million | CN¥65.35 Million | ▼ -53.1% |
| 2016 | 1.71x | CN¥78.21 Million | CN¥45.71 Million | ▲ +18.3% |
| 2015 | 1.45x | CN¥45.50 Million | CN¥31.47 Million | ▲ +465.6% |
| 2014 | 0.26x | CN¥10.51 Million | CN¥41.12 Million | ▲ +109.9% |
| 2013 | -2.59x | CN¥-70.31 Million | CN¥27.19 Million | ▼ -202.5% |
| 2012 | 2.52x | CN¥45.65 Million | CN¥18.09 Million | ▼ -54.5% |
| 2011 | 5.55x | CN¥55.06 Million | CN¥9.92 Million | ▲ +308.1% |
| 2010 | 1.36x | CN¥55.04 Million | CN¥40.48 Million | ▼ -0.5% |
| 2009 | 1.37x | CN¥32.41 Million | CN¥23.71 Million | ▼ -58.3% |
| 2008 | 3.28x | CN¥49.82 Million | CN¥15.20 Million | ▼ -65.1% |
| 2007 | 9.38x | CN¥55.26 Million | CN¥5.89 Million | ▲ +473.0% |
| 2006 | 1.64x | CN¥36.27 Million | CN¥22.15 Million | ▼ -56.4% |
| 2005 | 3.76x | CN¥34.88 Million | CN¥9.28 Million | ▲ +422.3% |
| 2004 | -1.17x | CN¥-11.72 Million | CN¥10.04 Million | ▼ -84.5% |
| 2003 | -0.63x | CN¥-11.46 Million | CN¥18.12 Million | ▼ -255.9% |
| 2002 | 0.41x | CN¥10.48 Million | CN¥25.82 Million | ▼ -57.4% |
| 2001 | 0.95x | CN¥23.57 Million | CN¥24.77 Million | ▼ -3.4% |
| 2000 | 0.99x | CN¥25.88 Million | CN¥26.27 Million | ▲ +739.6% |
| 1999 | 0.12x | CN¥1.01 Million | CN¥8.64 Million | — |